RFX6 Gene Mutation can Lead to a New Type of Diabetes

Mutation in RFX6 gene can give rise to a new type of diabetes, found a research team at ULB Center for Diabetes Research and the Erasmus Hospital ULB

Genetic mutation in RFX6 gene can lead to a new type of diabetes found a new study published in Nature communications journal.

A Scientific research team at the ULB Center for Diabetes Research and the Erasmus Hospital of the ULB has led to the identification of a new type of diabetes caused by a mutation in the gene RFX6.

Neonatal Diabetes may Be Caused by Mutations in the Insulin Gene
Neonatal diabetes which is an unusual form of diabetes may be caused by mutations in the insulin gene that affects very young children and results in lifelong

TOP INSIGHT

Individuals carrying the RFX6 mutation have a high probability of developing diabetes: it can start early, before the age of 20 years

Scientists from the ULB Center for Diabetes Research and the Erasmus Hospital of the ULB, together with colleagues at the University of Exeter (UK), University of Helsinki (Finland) and Kyoto University (Japan), have identified a new type of diabetes caused by a mutation in the gene RFX6.

Individuals carrying the RFX6 mutation have a high probability of developing diabetes: it can start early, before the age of 20 years, and by the age of 50 years, 80% of the patients might have developed the disease.

It is transmitted from parents to children and may affect many generations in the same family. RFX6 diabetes often requires insulin treatment because patients have reduced insulin secretion by the pancreas.

Gene Signature Identified for Diabetes Prediction
A gene signature has been identified for diabetes, where 80 small variations in the genes are found to influence the risk for diabetes.

Dr. Miriam Cnop, Professor at the ULB Center for Diabetes Research and the Erasmus Hospital, identified in these patients a reduced production of the hormone GIP( Gastric Inhibitory Peptide ) that stimulates insulin secretion.

The hormone GIP is produced by the intestine after eating and is an important regulator of insulin secretion.

CRISPR Gene Therapy Via Skin Transplant Treats Diabetes, Obesity
A novel form of gene-therapy done through skin transplantation treats two related and extremely common human ailments such as type-2 diabetes and obesity.

RFX6 diabetes is the first type of diabetes discovered to be related to low GIP production.

The identification of this novel disease mechanism suggests that GIP analogs ( drugs with a structure similar to GIP) may provide a novel treatment option for patients with RFX6 diabetes.

Monogenic Forms of Diabetes - Frequently Asked Questions
Do you know which doctor should you consult if you have Monogenic Forms of Diabetes. This and other commonly asked questions about this condition.

These new observations emphasize the need to identify specific forms of diabetes to provide personalized therapy to patients.

Source-Eurekalert